Treatment of depression in Parkinson's disease with moclobemide: A pilot open-label study.

Abstract:

:Moclobemide, a potent reversible monoamine-oxidase A (MAO-A) inhibitor, is an effective antidepressant that does not cause impairment of cognitive function in elderly patients and might be beneficial to motor deficits in Parkinson's disease (PD). In a 12-week open-label prospective study, we administered moclobemide (300-600 mg day(-1)) as an add-on medication to twelve PD patients who met DSM-III-R criteria for depressive illness. There were two early drop-outs due to subjective worsening of Parkinsonism associated with insomnia and anorexia, respectively. The Beck Depression Inventory score decreased significantly in the ten patients who completed the study, and clinical global assessment of efficacy recorded 'good' or 'excellent' responses or in nine of the ten patients. Mean parkinsonian disability, as assessed by the Unified Parkinson's Disease Rating Scale (UPDRS) and Schwab-England Daily Life Activities scales, remained unchanged throughout the study in the group as a whole. However, worsening or onset of resting tremor occurred in five patients and the UPDRS tremor subscore in the group overall was significantly higher by week 8 (p = 0.03) when dose titration was optimal. There was a trend toward improvement in UPDRS bradykinesia subscores that did not attain statistical significance. Compared to baseline, patients complained more often of insomnia, anorexia, increased perspiration, and restlessness. Though these preliminary results need to be replicated in a large controlled trial, we suggest that moclobemide may be an effective alternative in the treatment of PD associated depression.

authors

Giménez-Roldán S,Dobato JL,Mateo D

doi

10.1016/s1353-8020(97)00028-x

subject

Has Abstract

pub_date

1997-12-01 00:00:00

pages

219-25

issue

4

eissn

1353-8020

issn

1873-5126

pii

S1353-8020(97)00028-X

journal_volume

3

pub_type

杂志文章
  • Comment on Akbar et al., "Valbenazine-induced parkinsonism".

    abstract::This letter to the editor acknowledges the contribution of Akbar et al. to the field of tardive dyskinesia (TD) and provides important regulatory information about the potential for parkinson-like symptoms in patients with TD who are treated with valbenazine. ...

    journal_title:Parkinsonism & related disorders

    pub_type: 评论,信件

    doi:10.1016/j.parkreldis.2020.01.011

    authors: Shah C

    更新日期:2020-02-01 00:00:00

  • Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.

    abstract:INTRODUCTION:Cognitive decline is common in Parkinson's disease (PD), and identifying patients at highest risk for it is essential. We aimed to examine the effect of possible REM sleep behavior disorder (pRBD) on rate of cognitive decline in early PD, for both global cognition and in specific cognitive domains. METHOD...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.parkreldis.2016.03.006

    authors: Chahine LM,Xie SX,Simuni T,Tran B,Postuma R,Amara A,Oertel WH,Iranzo A,Scordia C,Fullard M,Linder C,Purri R,Darin A,Rennert L,Videnovic A,Del Riva P,Weintraub D

    更新日期:2016-06-01 00:00:00

  • Low body mass index and life prognosis in Parkinson's disease.

    abstract:INTRODUCTION:Patients with Parkinson's disease (PD) frequently lose weight, even in the early stages of the disease. Our objective was to clarify the association between low body mass index (BMI) and life prognosis in PD. METHODS:We conducted a retrospective cohort study of 651 PD patients (380 females), with a primar...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2018.05.011

    authors: Park K,Oeda T,Kohsaka M,Tomita S,Umemura A,Sawada H

    更新日期:2018-10-01 00:00:00

  • Imaging executive functions in Parkinson's disease: An activation likelihood estimation meta-analysis.

    abstract:INTRODUCTION:Executive dysfunction is a common and early cognitive symptom in Parkinson's disease (PD) with a detrimental effect on quality of life of patients and their care givers. Thus, a number of neuroimaging studies investigated the underlying neural correlates of such an impairment. Results of individual studies...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.parkreldis.2019.02.015

    authors: Giehl K,Tahmasian M,Eickhoff SB,van Eimeren T

    更新日期:2019-06-01 00:00:00

  • Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.

    abstract::Recent studies delineate substantial genetic components in Parkinson's disease (PD). However, very few studies were performed in Sub-Saharan African populations. Here, we explore the contribution of known PD-causing genes in patients of indigenous Zambian ancestry. We studied thirty-nine Zambian patients, thirty-eight...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2012.02.018

    authors: Yonova-Doing E,Atadzhanov M,Quadri M,Kelly P,Shawa N,Musonda ST,Simons EJ,Breedveld GJ,Oostra BA,Bonifati V

    更新日期:2012-06-01 00:00:00

  • Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's.

    abstract:BACKGROUND:Non-motor symptoms (NMS) are common in Parkinson's disease (PD) and cause significant distress. A high rate of non-declaration of NMS by patients to healthcare providers (HCP) means that many NMS remain untreated. Current understanding of the factors preventing disclosure of NMS to HCPs is limited. The prese...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2019.04.014

    authors: Hurt CS,Rixon L,Chaudhuri KR,Moss-Morris R,Samuel M,Brown RG

    更新日期:2019-07-01 00:00:00

  • Optic nerve integrity as a visuospatial cognitive predictor in Parkinson's disease.

    abstract:OBJECTIVE:To explore the microstructural integrity of the optic nerve and its role as a cognitive predictor in patients with de novo Parkinson's disease (PD) using diffusion tensor image-based magnetic resonance scans. METHODS:We enrolled 82 patients with de novo PD, 36 patients with drug-induced parkinsonism (DIP), a...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2016.06.020

    authors: Lee JJ,Shin NY,Lee Y,Lee SK,Sohn YH,Lee PH

    更新日期:2016-10-01 00:00:00

  • Delayed administration of dopaminergic drugs is not associated with prolonged length of stay of hospitalized patients with Parkinson's disease.

    abstract:BACKGROUND:Punctual delivery of dopaminergic medication to Parkinson's disease (PD) patients may be important in optimizing disease control. We tested the hypothesis that prompt delivery of l-dopa medications to emergency hospital inpatients was associated with a decreased length of stay in hospital. METHODS:The study...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2016.11.004

    authors: Skelly R,Brown L,Fogarty A

    更新日期:2017-02-01 00:00:00

  • Utility of quantitative EEG in early Lewy body disease.

    abstract:INTRODUCTION:The reduction of background activity and the increase of low-frequency powers on electroencephalogram (EEG) correlate with cognitive impairment and have been suggested to be underpinned by cholinergic deficit. We aimed to investigate the ratio between α and θ band power (α/θ ratio), as a synoptic index of ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.05.007

    authors: Massa F,Meli R,Grazzini M,Famà F,De Carli F,Filippi L,Arnaldi D,Pardini M,Morbelli S,Nobili F

    更新日期:2020-06-01 00:00:00

  • Genetic analysis of NFE2L2 promoter variation in Taiwanese Parkinson's disease.

    abstract::Oxidative stress has been reported as one of the pathogeneses of Parkinson's disease (PD). Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that regulates the expression of the target genes involved in antioxidant pathway. The promoter polymorphisms of the Nrf2-encoding gene, NFE2L2, have b...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2012.10.018

    authors: Chen YC,Wu YR,Wu YC,Lee-Chen GJ,Chen CM

    更新日期:2013-02-01 00:00:00

  • Reduced orexin immunoreactivity in Perry syndrome and multiple system atrophy.

    abstract:INTRODUCTION:Orexin is a neuropeptide that plays a key role in maintaining a state of arousal, and possibly associates with sleep apnea syndrome (SAS). Reduced orexin immunoreactivity has been reported in various neurologic conditions such as narcolepsy, Alzheimer's disease, Lewy body disease and multiple system atroph...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2017.06.003

    authors: Mishima T,Kasanuki K,Koga S,Castanedes-Casey M,Wszolek ZK,Tsuboi Y,Dickson DW

    更新日期:2017-09-01 00:00:00

  • Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up.

    abstract:OBJECTIVES:To report the results of a national survey aimed at quantifying the current level of diffusion of Levodopa/carbidopa intestinal gel (LCIG) in Italy. METHODS:Sixty Parkinson's Disease (PD) specialists in Italy were invited to complete a survey covering issues on clinical and practical aspects of LCIG therapy...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.parkreldis.2017.02.020

    authors: Sensi M,Cossu G,Mancini F,Pilleri M,Zibetti M,Modugno N,Quatrale R,Tamma F,Antonini A,ITALIAN LEVODOPA CARBIDOPA INTESTINAL GEL WORKING GROUP.

    更新日期:2017-05-01 00:00:00

  • Could Mucuna pruriens be the answer to Parkinson's disease management in sub-Saharan Africa and other low-income countries worldwide?

    abstract::Parkinson's disease (PD) is a progressive, disabling, neurodegenerative disease that requires long term care and pharmaceutical treatment. Levodopa remains the gold standard treatment for PD globally, although it is largely unavailable and unaffordable for the majority of patients in many sub-Saharan African and other...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.03.002

    authors: Fothergill-Misbah N,Maroo H,Cham M,Pezzoli G,Walker R,Cilia R

    更新日期:2020-04-01 00:00:00

  • The effect of tau genotype on clinical features in FTDP-17.

    abstract::The clinical phenotype of frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) varies. This variability is seen not only between kindreds with different mutations but also in families sharing the same mutation. Inheritance of tau haplotype (H1) and genotype (H1/H1) has been established as a risk...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2005.01.003

    authors: Baba Y,Tsuboi Y,Baker MC,Uitti RJ,Hutton ML,Dickson DW,Farrer M,Putzke JD,Woodruff BK,Ghetti B,Murrell JR,Boeve BF,Petersen RC,Verpillat P,Brice A,Delisle MB,Rascol O,Arima K,Dysken MW,Yasuda M,Kobayashi T,Sunoh

    更新日期:2005-06-01 00:00:00

  • How to improve neuroprotection in Parkinson's disease?

    abstract::Several factors involved in the etiology of Parkinson's disease (PD) have been proposed, including genetic and environmental factors or even a combination of both. Thus, multiple cellular hits are likely to contribute to neurodegeneration in PD. If such a mechanism happens to occur, our therapeutic intervention may pe...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/S1353-8020(08)70026-9

    authors: Hirsch EC

    更新日期:2007-01-01 00:00:00

  • Stroop test performance in impulsive and non impulsive patients with Parkinson's disease.

    abstract::Impulsive personalities are considered to have a general impairment in cognitive flexibility and cortical inhibition. To examine this hypothesis we used a trial by trial Stroop task in impulsive and non impulsive patients with Parkinson's disease (PD) and recorded errors and reaction times (RT). We tested 28 impulsive...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2010.12.014

    authors: Djamshidian A,O'Sullivan SS,Lees A,Averbeck BB

    更新日期:2011-03-01 00:00:00

  • Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: a comparison with other clinical executive tasks.

    abstract::The Behavioural Assessment of the Dysexecutive Syndrome (BADS) is a neuropsychological battery developed with the intent of measuring a wide range of executive impairments. Although the psychometric characteristics of BADS have previously been investigated in distinct neurological disorders, data on its validity in Pa...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2009.07.011

    authors: Perfetti B,Varanese S,Mercuri P,Mancino E,Saggino A,Onofrj M

    更新日期:2010-01-01 00:00:00

  • From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease.

    abstract::The MPTP-treated primate has proved to be a highly predictive model of the effects of dopaminergic drugs in the symptomatic treatment of Parkinson's disease (PD) and for the avoidance of motor complications. Using MPTP-treated primates, new dopaminergic therapies have been devised alongside novel treatment strategies ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/S1353-8020(09)70829-6

    authors: Jenner P

    更新日期:2009-12-01 00:00:00

  • Obsessive compulsive personality disorder in Progressive Supranuclear Palsy, Multiple System Atrophy and Essential Tremor.

    abstract:INTRODUCTION:aim of the study was to evaluate the presence of the Obsessive Compulsive Personality Disorder (OCPeD) in Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP) and Essential Tremor (ET) and in a group of healthy subjects. METHODS:patients affected by MSA, PSP and ET diagnosed according to cu...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2016.06.015

    authors: Nicoletti A,Luca A,Luca M,Donzuso G,Mostile G,Raciti L,Contrafatto D,Dibilio V,Sciacca G,Cicero CE,Vasta R,Petralia A,Zappia M

    更新日期:2016-09-01 00:00:00

  • Prevalence survey of movement disorders, epilepsy, hypertension and smoking habit in Vejer de la Frontera, Southern Spain-I. Methodology.

    abstract::A prevalence survey of movement disorders, epilepsy, hypertension and smoking was undertaken in Vejer de la Frontera, Southern Spain in 1988. A validated screening instrument designed for door-to-door tracing of specific disorders was used. Neurological diagnoses were based on: (1) direct anamnesis and examination by ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/s1353-8020(96)00021-1

    authors: Acosta-Varo J,De Pedro-Cuesta J

    更新日期:1996-10-01 00:00:00

  • Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.

    abstract:BACKGROUND:Parkinson disease (PD) and multiple system atrophy (MSA) share some neuropathologic features (nigrostriatal dopaminergic lesion, alpha-synuclein deposition) but not others (Lewy bodies in PD, glial cytoplasmic inclusions in MSA). In PD evidence has accrued for a vesicular storage defect and decreased aldehyd...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2015.03.006

    authors: Goldstein DS,Sullivan P,Holmes C,Kopin IJ,Sharabi Y,Mash DC

    更新日期:2015-06-01 00:00:00

  • Inhibition of dopamine uptake into PC-12 cells by analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

    abstract::The inhibition of uptake of radioactive dopamine into PC-12 cells by analogues of MPTP with systematic variations of structure was studied in order to assess the steric constraints of the transmembrane dopamine transporter. Of 15 analogues tested, 11 were found to inhibit dopamine uptake, all being competitive inhibit...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/1353-8020(95)00020-8

    authors: Athwal NS,Ramsden DB,Simpson M,Williams AC

    更新日期:1996-01-01 00:00:00

  • Use of efficacy probability maps for the post-operative programming of deep brain stimulation in essential tremor.

    abstract:INTRODUCTION:Post-operative programming of deep brain stimulation for movement disorders can be both time consuming and difficult, which can delay the optimal symptom control for the patient. Probabilistic maps of stimulation response could improve programming efficiency and optimization. METHODS:The clinically select...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2014.09.004

    authors: Phibbs FT,Pallavaram S,Tolleson C,D'Haese PF,Dawant BM

    更新日期:2014-12-01 00:00:00

  • Validation of diagnostic criteria for apathy in Parkinson's disease.

    abstract:BACKGROUND:Apathy is a common neuropsychiatric syndrome in Parkinson's Disease (PD) that affects quality of life. Research into apathy has been hampered by a lack of broadly accepted diagnostic criteria. Recently, diagnostic criteria for apathy in neuropsychiatric disorders have been proposed, which to date have not be...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2010.08.015

    authors: Drijgers RL,Dujardin K,Reijnders JS,Defebvre L,Leentjens AF

    更新日期:2010-12-01 00:00:00

  • The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment.

    abstract::Spinocerebellar ataxia (SCA) 17 is a dominant neurodegenerative disorder characterized by ataxia, cognitive decline, dystonia, and parkinsonism. The disease is caused by unstable cytosine-adenine-guanine (CAG) trinucleotide expansion mutation coding for polyglutamine tracts in the TATA box-binding protein (TBP), a gen...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2006.04.009

    authors: Lin IS,Wu RM,Lee-Chen GJ,Shan DE,Gwinn-Hardy K

    更新日期:2007-05-01 00:00:00

  • Defining delirium in idiopathic Parkinson's disease: A systematic review.

    abstract:BACKGROUND:Parkinson's disease patients may be at increased risk of delirium and developing adverse outcomes, such as cognitive decline and increased mortality. Delirium is an acute state of confusion that has overlapping symptoms with Parkinson's dementia, making it difficult to identify. This study aimed to determine...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2018.09.025

    authors: Lawson RA,McDonald C,Burn DJ

    更新日期:2019-07-01 00:00:00

  • Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.

    abstract:INTRODUCTION:Mutations in the LRRK2 and alpha-synuclein (SNCA) genes are well-established causes of autosomal dominant Parkinson's disease (PD). However, their frequency differs widely between ethnic groups. Only three studies have screened all coding regions of LRRK2 and SNCA in European samples so far. In Turkey, the...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2017.12.007

    authors: Kessler C,Atasu B,Hanagasi H,Simón-Sánchez J,Hauser AK,Pak M,Bilgic B,Erginel-Unaltuna N,Gurvit H,Gasser T,Lohmann E

    更新日期:2018-03-01 00:00:00

  • Striatal spine plasticity in Parkinson's disease: pathological or not?

    abstract::Parkinson's disease (PD) is characterized by a dramatic loss of dopamine that underlies complex structural and functional changes in striatal projection neurons. A key alteration that has been reported in various rodent models and PD patients is a significant reduction in striatal dendritic spine density. Our recent f...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/S1353-8020(09)70805-3

    authors: Smith Y,Villalba RM,Raju DV

    更新日期:2009-12-01 00:00:00

  • Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.

    abstract:INTRODUCTION:Two phase3 studies (SP512; SP513) involving mostly Caucasian patients showed that rotigotine (≤8 mg/24 h) was efficacious and welltolerated in early-stage Parkinson's disease (PD). We report results from a phase 3 study (SP0914/NCT01646268) investigating rotigotine in Chinese patients with early-stage PD. ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.parkreldis.2016.04.022

    authors: Zhang ZX,Shang HF,Hu X,Chen S,Zhao Z,Du X,Surmann E,Bauer L,Asgharnejad M

    更新日期:2016-07-01 00:00:00

  • Lessons learned from a large single center cohort of patients referred for DBS management.

    abstract:BACKGROUND:Deep brain stimulation surgery (DBS) for movement disorders has become commonplace and patients are beginning to present to specialized centers for second opinions. We aimed to uncover reasons for referral by analyzing a large single center cohort of DBS patients referred for management. METHODS:Data were c...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2010.05.003

    authors: Kluger BM,Foote KD,Jacobson CE,Okun MS

    更新日期:2011-05-01 00:00:00